University of California San Francisco Give to UCSF

The Ward 86 HIV Clinic in the Division of HIV, Infectious Diseases, and Global Medicine at San Francisco General Hospital is celebrating its 40th year in January 2023.

Please come celebrate the 40th anniversary of Ward 86 and a launch of our new initiative for 2022-2023 for Ward 86 on long-acting treatment and prevention. The program will feature a talk on the history of Ward 86, our new program (SPLASH), and hear from patients on their perspectives.

Kindly note that attendance will be limited to UCSF/ZSFG faculty and staff members of the San Francisco HIV community.

More on the new Ward 86 Program, SPLASH (Special Programs on Long-Acting Antiretrovirals to Stop HIV)

In January 2021, the FDA approved two long-acting antiretroviral medications administered together as intramuscular injections to treat HIV infection and in December 2021, the FDA approved one of these to prevent HIV infection in those at risk as pre-exposure prophylaxis (PrEP).  These injectable agents for treatment are approved only for people living with HIV who have already achieved virologic suppression on an orally-administered antiretroviral therapy (ART) but there are various barriers to taking oral ART daily for patients in our safety-net system. Ward 86 has launched the first program in the country to give these long-acting medications to patients in vulnerable patients with adherence-challenges. This is an innovative first-in-the-country program (gaining attention from the HIV community) to suppress or prevent HIV with the latest innovations in HIV.


Event Details

  • Marc Vincent

1 person is interested in this event